Viz.ai Achieves ISO/IEC 42001 Certification, Setting the Standard for Agentic AI in Healthcare

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it has successfully achieved ISO/IEC 42001 certification, the international standard for Artificial Intelligence Management Systems (AIMS), following an independent audit conducted by an accredited certification body.

As one of the first companies globally to achieve this accredited ISO/IEC 42001 certification, this milestone marks a significant step in formalizing how Viz.ai governs artificial intelligence across its entire lifecycle, from design and development to deployment, monitoring, and ongoing improvement. ISO/IEC 42001 establishes a structured framework for managing AI systems, with defined requirements for risk management, impact assessment, and accountability.

“Agentic AI workflows are becoming central to how we deliver clinical value at Viz.ai, and this certification reflects how we have operationalized responsible AI across the company,” said Tom Vaknin, Chief Information Security Officer at Viz.ai. “We operate as a leading AI provider, producer, and user, and the audit validated that we manage all three roles with clear ownership, defined controls, and continuous oversight.”

For Viz.ai’s customers, this ISO/IEC 42001 certification translates directly into enhanced assurance and reduced risk. Hospital systems gain confidence in the safety and reliability of Viz.ai’s platform, knowing that critical AI workflows, from detecting disease to coordinating care, are managed under a globally recognized, independently audited framework for bias, safety, and performance oversight. Life sciences partners benefit from working with a validated AI provider, simplifying their own due diligence and ensuring their commercial AI strategies are built on a foundation of responsible, compliant, and continuously monitored AI governance. This certification also reinforces what clinicians and health system leaders confirmed in the 2026 Black Book AI Clinical Decision Support survey: Viz.ai ranked #1 overall and received the top score in both Security, Privacy, & Governance and Regulatory Readiness & Algorithm Lifecycle Management, making it the only platform in its class with both independent clinical validation and accredited AI governance certification.

Key areas evaluated during the audit included:

  • Governance structure and clear accountability for AI systems

  • Risk and impact assessments addressing safety, bias, and misuse

  • Data governance and data set management practices

  • Algorithm performance monitoring and lifecycle controls

  • Integration of AI oversight into engineering, product, and quality processes

ISO/IEC 42001 requires organizations to adopt a dynamic, risk-based approach to AI, including continuous monitoring, human oversight, and documented impact assessments. Viz.ai has embedded these capabilities into its core management system, not as a standalone initiative, but as part of how the company operates every day. With this certification, Viz.ai reinforces its position at the forefront of responsible agentic AI in healthcare, aligning innovation with governance, regulatory expectations, and real-world clinical impact.

About Viz.ai

Viz.ai is the leader in building and deploying AI-powered Care Pathways and helping doctors do their work. The Viz Platform is deployed in 2,000 hospitals across the United States and trusted by many of the leading life sciences companies. The platform uniquely combines real-time, multimodal clinical data with deep clinician engagement to detect disease earlier, coordinate care teams, and help ensure patients receive the right treatment faster. Viz.ai was the first company to be awarded CMS reimbursement for AI and is ranked the #1 Healthcare AI Platform by hospitals and health systems in the Black Book Research survey. For more information, visit Viz.ai.

Media gallery